Discover our new webpage dedicated to 90 years of HA
and download our White paper now!
Press releases
September 30, 2021
HTL launches a new bioproduction unit HTL4
Representing an investment of more than 50 million euros, this new unit dedicated to the bioproduction of pharmaceutical-grade hyaluronic acid represents a pivotal stage in the development of HTL and the largest investment ever made in the world for a biopolymer production unit.
It will enable HTL to become the largest producer of pharmaceutical-grade hyaluronic acid in the world and accelerate its international development.
Read more below.
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Articles November 14, 2024Discover our new webpage dedicated to 90 years of HA and download our White Paper!
and download our White paper now!
-
Articles October 8, 2024HTL Biotechnology at CPHI Milano
As the leading global event for the pharmaceutical industry, CPHI Milan brought together key stakeholders from across the sector to foster connections and innovation.
-
Articles October 4, 20241st symposium for HTL Biotechnology at MAIS congress
As a key event for regenerative medicine and biotech innovation, the MAIS Congress in Marbella brought together leading professionals to explore the latest advancements in the field. A unique opportunity to share with the medical aesthetic community our biopolymers platform.